MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $567,657 | -36.5% | 3,887 | +0.5% | 0.00% | -50.0% |
Q2 2023 | $893,277 | +3.1% | 3,867 | +8.1% | 0.00% | 0.0% |
Q1 2023 | $866,564 | -34.5% | 3,577 | -21.5% | 0.00% | -33.3% |
Q4 2022 | $1,322,669 | +258.4% | 4,557 | -19.7% | 0.00% | +200.0% |
Q3 2022 | $369,000 | -28.6% | 5,677 | -21.4% | 0.00% | 0.0% |
Q2 2022 | $517,000 | -33.8% | 7,227 | -9.2% | 0.00% | -50.0% |
Q1 2022 | $781,000 | +15.9% | 7,957 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $674,000 | +6.1% | 7,957 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $635,000 | -14.9% | 7,957 | +3.9% | 0.00% | 0.0% |
Q2 2021 | $746,000 | +32.3% | 7,657 | +58.9% | 0.00% | 0.0% |
Q1 2021 | $564,000 | -3.3% | 4,820 | -8.0% | 0.00% | 0.0% |
Q4 2020 | $583,000 | -15.6% | 5,240 | -10.0% | 0.00% | -50.0% |
Q3 2020 | $691,000 | +26.1% | 5,820 | +20.2% | 0.00% | +100.0% |
Q2 2020 | $548,000 | +65.6% | 4,840 | -2.4% | 0.00% | 0.0% |
Q1 2020 | $331,000 | -26.8% | 4,960 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $452,000 | +3.0% | 4,960 | -2.6% | 0.00% | 0.0% |
Q3 2019 | $439,000 | -22.4% | 5,090 | -5.7% | 0.00% | 0.0% |
Q2 2019 | $566,000 | +35.4% | 5,399 | +61.7% | 0.00% | 0.0% |
Q1 2019 | $418,000 | +11.2% | 3,339 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $376,000 | -31.8% | 3,339 | +29.8% | 0.00% | 0.0% |
Q3 2018 | $551,000 | -6.3% | 2,572 | +22.4% | 0.00% | -50.0% |
Q2 2018 | $588,000 | – | 2,102 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |